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ABSTRACT 
The pregnancy-specific beta- I glycoproteins (PSG) are a family of abundant proteins 
essential to pregnancy that are encoded by 11 genes located on chromosome l 9q 13 . 1-
13 . 3. The genes can be divided into three subgroups based on the organisation of their 3' 
coding regions. In 1989, our group isolated cosmid hC3 .11 , which contained most of the 
PSG 11 gene, but which did not include the 3' coding region. This thesis reports 
subsequent work to characterise two further cosmids which span the PSG 11 locus and 
which do include the 3' coding region. These cosmids were mapped and partially 
sequenced. 
Three exons encoding potential alternative C-terminal domains were identified: Cw, Cr 
and Cs. The Cs domain lies 4.6kb from the end of the B2 domain. This is the first report 
of genomic sequence for this particular domain and for a functional PSG subgroup 3 
gene. 
Downstream from this exon are sequences homologous to the C-termini of subgroup I 
PSG genes. This finding suggests that subgroup 1, 2 and 3 genes are related via 
insertion/deletion events. 
Data from seven PSG genes from all three subgroups and from four different regions 
were used to construct evolutionary trees. Variability patterns in the data were examined 
and these showed that the mechanism of sequence evolution for the N-terminal domain, 
the A 1 domain, and to a certain extent, the B2 domain was not neutral. Sequences from 
these regions were shown to be unsuitable for determining historical relationships 
between PSG genes. In contrast, the data from the C-terminal region showed a better fit 
with the assumptions of sequence evolution ( e.g. all changes are independent and 
identically distributed) required by currently implemented analysis methods. Evolutionary 
tree reconstruction using this region gave a phylogeny _that was consistent with one 
based on the genomic organisation of the genes. 
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CHAPTER 1. INTRODUCTION 
1.1 The Placenta 
The placenta is the organ primarily responsible for the interchange of substances between the 
developing foetus and the mother. As such, it performs a number of functions such as gaseous 
exchange, the supply of nutrients, the removal of waste products, the production and exchange 
of proteins and hormones as well as providing some immunological and physical protection as 
a barrier. The placenta is therefore a unique organ with several distinctive characteristics. It has 
a dual origin being derived from both maternal and foetal tissues. It has extensive contact 
between foetal chorionic villi and the maternal blood system. Because of its function it has both 
a limited life span and an extracoporeal position with respect to the foetus (Hamilton et al. , 
1972). 
Although much of the interchange of materials between the foetus and the mother is achieved 
by simple diffusion, the placenta cannot be considered to be an inert barrier. There is evidence 
that many substances, including nutrients are actively transported against a concentration 
gradient. Pinocytosis is thought to be involved in the transport of some immunologically 
important macromolecules from the maternal blood system to the foetus (Hamilton et al., 
1972). In a recent theoretical paper (Guilbert et al. , 1993), the placenta is likened to a 
completely syncitialised macrophage which "surrounds and protects the antigenically foreign 
conceptus in a manner analogous to the formation of cyst-like structures by giant cells 
(syncitialised macrophages) that envelop potentially harmful pathological agents". Indeed, it 
appears placental tissue and macrophages share many characteristics such as phagocytosis, 
syncitialisation, invasiveness and the expression of proteins such as CD4, CD 14, IgG receptor 
(FcR), colony stimulating factor-I (CSF-1), granulocyte macrophage-CSF (GM-CSF), 
interleukins I and 6 (IL-1, IL-6), tumour necrosis factor (TNF), transforming growth factor 
(TGF), platelet derived growth factor (PDGF) and receptors for these cytokines. 
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Tl,e immunological relationship between mother and foetus 
The placenta and developing foetus are not antigenically inert either. Why this unit is 
maintained, without eliciting an immunological graft rejection response, is a question for which 
there is as yet no satisfactory explanation. The unique immunological relationship between the 
mother and the developing foeto-placental unit is extremely complex. Two hypotheses 
proposed for explaining the specific non-reactivity of the maternal immune system to the 
conceptus are immuno-tolerance and immunoenhancement. 
When the immune system is exposed to either very high or very low doses of antigen, it may 
fail to respond to the antigen; this is known as immuno- tolerance. It is possible that during 
gestation, small numbers of foetal cells sloe off into the maternal blood system, providing a low 
dose of antigen. Although the two systems are quite separate, there is some evidence that foetal 
erythrocytes, lymphocytes and syncitial sprouts mix with the maternal blood. Erythrocytes do 
not possess transplantation antigens and the antigenic status of the sprouts is unknown. 
Lymphocytes however, probably do possess transplantation antigens and may contribute to 
"low zone" immuno-tolerance (Hamilton et al. , 1972). 
Immunological enhancement is "the specific frustration of both the antigenic stimulus and the 
hosts cellular immune response, mediated by humoral isoantibody" (Beer and Billingham, 
1976. ). The mechanism of enhancement is not fully understood but it seems to involve the 
masking of antigen by antibody which inhibits attack by cytotoxic T cells and/or helper T cells 
and/or blocking of receptors on cytotoxic T cells by antigen shed from the target cell (Roitt, 
1980). Some kind of central inhibitory action by antibodies or antibody/antigen complexes, to 
impair the development of the host cell-mediated immune response is also thought to be 
involved (Beer and Billingham, 1976). 
Some aspects of the unique immunological relationship between the mother and the developing 
foetus are partially understood: 
The maternal immune system appears to be "cognisant" of the antigenically foreign conceptus. 
Indeed, recognition of genetic disparity seems to be essential for successful implantation and 
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placental expansion (Guilbert et al., 1993, Beer and Billingham, 1976). Also it appears that the 
uterus is able to express a normal immune response in other circumstances - that is - it does not 
appear to be an immunologically privileged site (Hamilton et al., 1972). 
There is some evidence from mouse and human studies, that pregnant individuals are biased in 
their immune response, toward humoral (antibody) responses and away from cell-mediated 
immunity (Guilbert et al., 1993, Mosmann and Moore, 1991). THI and TH2 lymphocytes are at 
least partially responsible for cell-mediated and antibody responses respectively and produce a 
number of cytokines that cross-regulate an equilibrium between the two subsets of cells in non-
pregnant individuals. Interleukin-10 (IL-10) is one such cytokine. It is produced by TH2 cells 
and inhibits the synthesis of cytokines by THI cells. IL-10 has been found to be expressed 
constitutively at the foeto-matemal interface during all three trimesters of pregnancy (Guilbert 
et al., 1993). Other cytokines such as TGF-B, have been similarly detected. As well as 
functioning as growth stimulators, with a role in placental expansion, they may also help to 
establish the switch toward antibody responses during pregnancy. Interactions at the level of 
cytokine regulation are however, extremely complex and require further investigation to 
uncover all the pathways involved. 
1.2 The PSG - A Major Class of Placental Proteins 
One of the most abundant classes of proteins produced by the placenta are the pregnancy-
specific J3-l glycoproteins (PSG). The PSG are a heterogeneous family of proteins whose 
levels increase in an exponential manner during pregnancy, reaching final concentrations of 
200-400µg/ml in maternal serum (Oikawaeta/. , 1989, Lin etal., 1974). High levels ofPSG 
during pregnancy correlate with stable pregnancy while decreased levels are associated with 
threatened miscarriage (Tamsen et al., 1983). 
The PSG are classified as a subgroup of the carcinoembryonic antigen (CEA) gene family on 
the basis of sequence identity. Both PSG and CEA proteins are predicted to contain the looped 
domains characteristic of members of the immunoglobulin superfarnily (Paxton et al.1987, 
Zheng et al., 1990 and FIG. I). The observation of high levels during stable pregnancies, 
suggests the PSG may have an essential role during pregnancy, though this has yet to be 
PSGl 
CEA 
N-CAM 
ss Disulphide bond 
~ GPI linkage 
~ Transmembrane region 
I\) Cytoplasmic domain 
BGP 
PSG2 
PSGS 
CD2 
Thyl 
FIG. 1. Schematic representation of some members of the immunoglobulin 
superfamily (from Khan et al, 1992). 
Filled circles represent variable region (V) - like domains. Circles closed with the letters 
ss represent C2-type constant domains. Homologous domains are indicated with the 
letters N, Al, A2, BI, B2. 
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determined. Detailed characterisation of the PSG genes will provide a basis for future research 
into a biological role for PSG. 
A brief historical perspective 
In 1970, Tatarinov and Masyukevich isolated a new protein from human pregnant serum which 
they called P APP-C (Tatarinov and Masyukevich, 1970). A year later, Bohn isolated a protein 
from human placenta named Schwangerschafts protein-I (SPl ), which proved to be 
immunologically identical to P APP-C (Bohn, 1971 ). The protein was later found to be a 
collection of glycoproteins with molecular masses between 70kda and 3 2kda and a 
carbohydrate content of 28-32% (Watanabe and Chou, 1988a) and were subsequently called 
pregnancy-specific J3- l glycoproteins. Initially PSG were thought to be specific to the placenta 
but later studies detected the proteins in foetal liver cells (Zimmerman et al., 1989), salivary 
gland and colon (Zoubir et al., 1990), testes (Borjigin et al., 1990), in various tumour cell lines, 
as well as in the sera of patients with hydatidiform mole, invasive mole and choriocarcinoma 
(Chou and Plouzek, 1992). However, the placenta remains the major site of production of 
PSG. 
Early experimental work using antibodies to the protein showed that human PSG were a 
heterogeneous group of proteins, which were thought to be related via post-translational 
modifications. The extent of this heterogeneity was not appreciated however until molecular 
studies were undertaken and it became apparent that there were several PSG genes. By the late 
1980s, a number of cDNA clones had been independently isolated (Watanabe and Chou, 1988a 
and b, Rooney et al., 1988, Chan et al., 1988a, Streydio et al., 1988, Khan and Hanunarstrom, 
1989, McLenachan and Mansfield, 1989, Zimmerman et al., 1989). Subsequently, genomic 
clones were isolated and the genomic organisation of some PSG established (Oikawa et 
al., 1988, Oikawa et al. , 1989a). The genes were mapped as a cluster on chromosome 19 
(Streydio et al., 1990, Thompson et al., 1990) and estimates of the size of the family based on 
the number of 5' exons detectable in the genome, suggested that there were at least 9 different 
genes. Many of these had alternative splice and/or polyadenylation variants, giving rise to more 
than thirty different transcripts. 
Table 1. CLASSIFICATION OF THE HUMAN CEA/PSG GENE FAMILY. 
(from: Chou and Plouzek, 1992, Barnett and Zimmerman, 1990) 
CEA subfamily. 
--------------------------------
current name of_,;,:en=-:_e :::_:orc:mRN=:.::A:_:__ _____________ o:.:ld=-=nam= e-=--s -'-'of'--"-'-en=•cc• c:.or'--'mRN=-=:.::A:_:__ _ __________ __ _ 
CEA 
CEAa 
CEAb 
NCA 
BGPa 
BGPb 
BGPc 
BGPd 
BGPe 
BGP£ 
BGPg 
BGPh 
BGPi 
CGMI 
CGMh 
CGMJb 
CGMlc 
CGMZ 
CGM6 
CGM7 
CGM8 
PSG subfamily. 
CEA 
CEA 
CEA 
NCA 
BGPl, TM-1 
TM-2CEA 
TM-3CEA 
TM-4CEA 
4-22 
4-13 
W211 
W233 
W239 
hsCGMl 
CGMJa, W264 
W282 
CGMJc 
hsCGl\.12 
hsCGM6, GN-1, M6, NCA-W272 
W236 
CGM8 
current name of gene or mRN A ___________ ___ old names of eneormRNA 
PSGl 
PSGh 
PSGlb 
PSGJc 
PSGld 
PSGle 
PSGI-Ila 
PSGl-1 
PSG2n 
PSG3m 
PSG4 
PS~ 
PSm 
PSm-In 
PSm-Im 
PSG6 
PSG6r 
PSG6s 
PSG7 
PSG8 
PSGh 
PSGlls 
PSGll-lw 
PSG14 
PSGJ5 
PSGJ6a __ , __ ..__,._ ...,. __________ _ 
PSPG 
PSG93, PSl3G-O, hPSPl 1, FL-NCA-2, hPS3, PSGla, PS(JG81 
PSGJ6 
PS PG-C 
FL-NCA-1 , PSGJd, SG9 
PSPG-C~ PSG95 
PSPGD 
PSGJ-1 
PSPG-E, SGS, hPS184 
pSP-~ hC17, PS35, hTSl6, PSPGA. sm, hPS173 
PSG4, hsCGM4, hHSP2, FLl7 
PSG4, hPS 133, PSG9 
PSG5 
FL-NCA-3, hPS 176 
PSPG-lll.. (clone 22) 
hsCGM3, FL26,PSGGB 
PSG6 
bPSl2, PSGIO, hPS89 
PSG7, PSGGA 
CGM35,PSG8 
hTSI 
PS34, PSG-G, PSl3G B, PSG7 
hPS2, hPS91 
PSGJ4 
PSGl5 
PSG9 
In 1989, following a combined CEA/PSG workshop in Freiberg, Germany, a standard 
nomenclature was proposed by Barnett and Zimmerman (1990) and adopted world-wide. The 
current gene and transcript designations are presented in Table 1. 
The PSG genes are numbered 1 through 16, e.g. PSGl. The C-terminal splice variants are 
indicated with a lower case letter, eg.PSGla, while central domain splice variants are denoted 
by the roman numerals e.g. PSGI-Ila (Table 1 and FIG.2). 
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Most recent studies of the PSG include the fine mapping of the PSG and CEA genes to 
determine their relative positions and orientations on chromosome l 9q 13 .1-3 (Brandriff et al., 
1992, Thompson et al., 1992, Trask et al., 1993, Tynan et al., 1992, Olsen et al., 1994, 
Teglund and Hammarstrom, 1994), promoter analysis (Lei et al., 1992, Chou and Plouzek, 
1992) and initial studies on differential expression of specific PSG during pregnancy ( Streydio 
and Vassart, 1990, Chamberlin et al., 1994). The evolutionary history of the PSG genes has 
been investigated and an evolutionary tree based on N-terrninal nucleotide sequences proposed 
by Khan et al. (1992). A possible biological role for the PSG as haematopoetic growth factors 
has recently been investigated by Wu et al. ( 1993 ). 
Primary structure of the PSG 
To date no direct protein sequences have been determined for the PSG. There are also no 
crystal structure determinations. 
The primary structure of PSG, predicted from cDNA sequence, is as follows: 
a short leader peptide, (L), typically 34 amino acids long, is followed by an N-terrninal domain 
(N) of 109 amino acids ( except for PSG6 which has 108), one or two similar central domains 
(A) of93 amino acids, a single related central domain (B) of 86 amino acids and a C-terrninus 
(C) of varying length (3-81 amino acids -see Table 2). The PSGproteins can be divided into 
two types depending on the number of central domains occurring in the protein. Type I 
proteins contain 3 central domains, always Al, A2 and B2. Type II proteins contain only 2 
central domains, either Al, B2 (type Ila) or A2, B2 (type Ilb) (FIG. 2, Chou and Plouzek, 
1992). 
FIG. 2. Structure and organisation of the PSG cDNA and 
genes 
The domain structure of the PSG cDNA is predicted from amino 
acid sequence. There is a direct correspondence between the 
domains and the exons.All PSG genes contain six exons. The first 
(L), encodes part of the leader peptide. The second (LIN), encodes 
the rest of the leader peptide and a complete lg-V-like, N-terminal 
domain (N). The central exons (Al, BI, A2, B2) encode the IgC2-
constant-type domains. The B 1 exon is non-functional in all PSG 
characterised to date. The PSG transcripts can vary in the number 
of central domains they possess (Types I, Ila and lib). Also, each 
PSG gene can produce multiple transcripts via alternative splicing 
of the C-terminal exons (Ca, b, c, d, m/n, w, r and s). The PSG 
genes can be divided into subgroups 1, 2 and 3 on the basis of the 
organisation of their 3' regions. The dotted line indicates unavailable 
sequence data. 
SOME cDNA OF THE PSG SUBFAMILY 
PSGlls 5'UT A2 ~ 2=1] L N Al 
PSGlb 5'U1R ~ _[Al J B2 r b 1 3'UTR L N 
PSG5n J'U1R r{ ~G2 J B2 ln} 3' UTR 
GENOMIC ORGANISATION OF PSG GENES 
L L/N Al BI A2 B2 C 
dcab 
m/n 
3'U1R 
-0 , I··············· 
w r s 
~ I- -- D DJ - ~ ~ 
Type I 
Type Ila 
Type Ilb 
Subgroup 1 (PSG 1,4,7,8) 
Subgroup 2 (PSG 2,3,5) 
Subgroup 3 (PSG 6,11 ,12) 
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There is extensive similarity among members of the PSG family . The N-terminal domains of 
different PSG share around 90% and 96% similarity at the amino acid and nucleotide levels 
respectively, the A domains share 91 % and 96% similarity respectively and the B domains 
share 86% and 94% similarity respectively. In addition, the N, A and B domains are similar to 
each other. 
The C-terminal domains initially appeared to be the most variable part of the PSG . However 
as the genomic organisation of the different subgroups became known, it was found that 
comparable regions at the C terminus also share considerable nucleotide and amino acid 
similarity, varying between 63% (PSG 6 and 8), and 98% (PSG 2 and 5). A comparison of the 
C-terminal domains of reported PSG transcripts is presented in Table 2. 
The N-terminal domains of all PSG, with the exception of PSG 1, 4 and 8, contain an RGD 
( Arg-Gly-Asp) tripeptide. This motif is the minimum functional unit for the binding of a 
variety of adhesive proteins of the extracellular matrix and the blood, such as fibronectin, 
laminin, tenascin and collagen, to their receptors, the integrins. While this motif can arise 
without a functional role, its presence in the N domain provides a basis for the hypothesis that 
it may contribute to the biological activity of the protein. RGD-mediated events include 
interactions with the immune system, cell recognition, cellular architecture type interactions, 
and tumour metastasis (reviewed in Springer, 1990 and Ruoslahti and Piersbacher, 1987). The 
absence of the RGD tripeptide in some PSG suggests that they may have different biological 
roles. 
The A and B domains contain cysteine residues at conserved locations that have the potential to 
form disulphide bonds and make a looped secondary structure, characteristic of members of the 
immunoglobulin family (Paxton et al. , 1987, Zheng et al., 1990). The N domain, in contrast, 
does not have these conserved cysteine residues but retains the potential to fold, through 
interactions between hydrophobic residues at the predicted sites, and by a conserved salt bridge 
(Bates et al. , 1992). The N domain is similar to the lg-variable (IgV) type domains and the A 
and B domains to the Ig-C2 type constant domains (Williams, 1987). 
Table 2. PREDICTED AMINO ACID SEQUENCES FOR THE C-TERMINAL 
DOMAINS OF REPORTED PSG TRANSCRIPTS. 
Subgroup 1 
_gen=es~ _ 
PSGl 
PSG4 
PSG7 
PSG8 
Subgroup 2 
Ca 
DWTVP 
.. IL . 
.. SL . 
... L . 
Alternative C-terminal domains 
-- - --- --- - - --- -
Cb Cc Cd 
EAL AYSS SINYTSGNRN GKWI PASLAVGF 
na na na 
. s. . .. G ........ D. ...... . ..... 
. ........ AVY . . R .. V ..... I 
Alternative C-terminal domains 
~ ----------
PSG2 
PSG3 
PSG5 
Subgroup 3 
Cm/n 
ASTRIGLLPLLNPT 
. PSGT . H .. G ... L 
. PSG .. R ...... I 
Alternative C-terminal domains 
- ~ -------------------------------------------
PSGD 
PSGl 1 
Cr Cs Cw 
ETASPQVTYAGP GPCHGNQTESH 
NTWFQEILLL 
na 
na . . ... DL ... ES GKW I PASLAVGFYVESIWLSEK 
SQENIFIPSLCPMGTSKSQILL 
LNPPNLSLQTLFSLFFCFLMAD 
LVSGLKKVGRGLYQP 
dots indicate sequence identity . 
na : sequence not available. 
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The C-terminal domains vary from 3 to 81 amino acids. The majority are around 12 residues 
long. The exception is PSG 11 w which has an unusually long Cw domain of 81 residues. While 
most PSG are secreted, PSG 11 w is retained within the cell (Chen et al. , 1993 ). The C-terminal 
domains also vary in their hydrophobicity, e.g., PSGld, 7d and 8d have hydrophobic Cd 
domains and PSGlc, 7c and 8c have hydrophilic Cc domains. The 22 amino acid Cr domains 
of PSG11 and PSG6 are hydrophobic while the 12 and 11 amino acid Cs domains of PSGl 1 
and 6 respectively are hydrophilic. 
The significance of the variability at the C terminus of PSG proteins is unknown. The cell 
adhesion molecule N-CAM has three splice variants with different C termini. One variant is a 
glycosyl phosphitidyl inositol (GPI)-anchored form (ssd N-CAM) while the other two are 
transmembrane forms (sd N-CAM and Id N-CAM). The GPI-anchored form is targeted to the 
apical surface of polarised epithelial cells, whereas the sd and Id forms are expressed on the 
basolateral surface (Powell et al. , 1991 ). The different isoforms then, determine the cellular 
destination of a particular N-CAM molecule. While a similar role for the variable C-termini of 
PSG molecules is hard to imagine, as the majority are secreted, it is possible that particular C-
termini are involved in, or modify, particular interactions with particular cells in some way. 
Genomic structure and organisation of the PSG 
There have been many estimates of the number of genes in the PSG subfamily, based on a 
variety of methods including hybridisation cloning and sequencing of the N domains 
(Thompson et al. , 1989. Thompson et al. , 1990) as well as detection by PCR in blood and 
placental tissue (Khan et al. , 1992, Wu et al. , 1993). Most recently, a high resolution physical 
map has been constructed from overlapping cosmid clones, that spans the region of 
chromosome 19 which contains the CENPSG genes (Olsen et al. , 1994). This study has 
identified a total of twenty-nine genes belonging to the CENPSG family, including the PSG 
genes, genes for CEA, non-specific cross-reacting antigen (NCA), biliary glycoprotein-1 (BGP) 
and a number of CEA gene family members (CGMl-18). A centromeric cluster of six genes 
(cen- CGM10-CGM7-CGM2-CEA-NCA-CGM1), spanning 200kb, is separated by 560kb 
from cluster of twenty-three genes (BGP-CGM9-CGM6-CGM8-CGM12-PSG3-PSG8-
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CGM13-PSG12-PSG1-PSG6-PSG7-CGM14-PSG13-CGM15-PSG2-CGM16-PSGS-PSG4-
CGM17-PSG11-CGM18-CGM11-tel), which spans 860kb. 
All PSG genes characterised to date contain at least six exons encoding a S 'UTR and the first 
21 aa of the leader peptide (L, exon 1 ), the rest of the leader peptide and the N domain (LIN, 
exon 2), an A domain (Al, exon 3), a B domain that is never translated (BI, pseudoexon 4), a 
second A domain (A2, exon S) and a second B domain (B2, exon 6) (FIG.2) . There is an exact 
correlation between the protein domains and the exons. Following the B2 domain exon are a 
variable, gene-dependent number of exons encoding alternative C-term.inal domains and 3' 
UTR that are selected by alternative splicing. 
It is not clear whether the difference in the number of central domains between type I (L-N-
Al-A2-B2-C) and type II (L-N-Al-B2-C or L-N-A2-B2-C) proteins arises by alternative 
splicing or from genes with defective Al or A2 exons (Chou and Plouzek, 1992). 
It is clear, however, that the C-termini are alternatively spliced. PSG members can be divided 
into three different subgroups (1, 2 and 3) according to the organisation of their C-terminal 
domains (FIG.2). 
The genomic organisation of the C-terminal domains of subgroup 1 genes has been determined 
independently for PSGl , 4, 7 and 8 (Lei et al. , 1992, Thompson et al., 1990, Leslie et al. , 
1990, Oikawa et al. , 1988). The PSGl locus appears to produce five PSG, each containing a 
unique C terminus (PSG 1 a, I b, I c, Id, I e, ). These transcripts are generated by alternative 
splicing and the use of alternative polyadenylation signals . The Cd domain exon lies adjacent to 
the B2 exon in all PSG genes. However only transcripts from subgroup 1 genes (PSG 1,4,7, 
and 8) appear to use this exon . 
The genomic organisation for PSGS, a subgroup 2 gene, has been determined also (Thompson 
et al. , 1990, Oikawa et al. , 1989a) and the Cm/n region lies about 4.3 kb downstream from 
the end of the B2 domain. It appears the region lies on two exons with the Cm/n domain and 
the first 44bp of the 3 'UTR on the first exon and the remainder more than 2kb further 
downstream (Thompson et al., 1990). Only the first exon containing the Cm/n domain has been 
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sequenced and very little of the intervening intron sequence is available. The second exon is 
predicted from cDNA sequence. The Cm and Cn regions differ only in a deletion in the 3 ' UTR. 
The PSG 6, 11 and 12 are subgroup 3 genes. The cDNA PSG6s, PSG6r (Zimmerman et al. , 
1989, Bamettetal., 1990,Zhengetal. , 1990), PSGllsandPSGllw(Arakawaeta/. , 1991 , 
Brophy et al. , 1992, Zheng et al., 1990, Chan et al. , 1990) have been isolated and 
characterised. 
The PSG 12 gene is unreported although a pseudogene, PSG12'V, has been characterised (Lei 
et al., 1993 ). A region that could encode a Cr domain was identified approximately 3. 3 kb 
downstream from the end of the B2 domain. A region that could encode a Cs domain was not 
located but was predicted to lie more than 5kb downstream from the end of the B2 domain. 
Post translational modifications 
The PSG are highly glycoslyated proteins with carbohydrate contents ranging from 28% to 
32%. (Watanabe and Chou, 1988b). It is thought that the N-domain glycan moieties may be 
essential for the stability of the PSG protein (Chou and Plouzek, 1992). 
Sequence analysis of the deduced PSG protein also indicates the PSG may be highly 
phosphorylated proteins . The proteins contain consensus sequences for phosphorylation by 
casein kinase II and protein kinase C. There is also a consensus sequence present in the 82 
domains of all PSG, for tyrosine kinase. No experimental work has investigated the 
phosphorylation of PSG proteins. 
PSG synthesis and expression 
The primary site of synthesis of the PSG is in the syncytiotrophoblast cells of the placenta. 
These cells originate from the cytotrophoblast cells and form a ring around the developing 
blastocyst subsequent to implantation. By twelve days, the syncitium is full of large vacuoles or 
lacunae which form an interconnecting network. Syncitial cells penetrate into the endometrium 
and erode the endothelial lining of the surrounding maternal capillaries. As a consequence of 
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this, the lacunae fill up with maternal blood, setting up the uteroplacental circulation system by 
day thirteen (see FIG.3). By the end of the third week primary villi have developed. Lacunae 
are lined with syncitiotrophoblasts; these are the cells that have direct contact with the maternal 
blood and are intimately involved with the foetal/maternal exchange.(Ramsey and Donner, 
1980) 
Syncitiotrophoblasts are known to synthesise and secrete a wide variety of products which 
include oestrogenic hormones (mainly estriol), progesterone, human chorionic gonadotrophin 
and human chorionic somatomarnmotropin (Hamilton et al., l 972). The PSG can be detected 
three to four days post fertilisation and are regulated independently of other products such as 
hCG. 
The PSG are secreted into maternal serum throughout the duration of pregnancy in a pulsatile 
fashion with the pulse frequency increasing as the pregnancy progresses. Throughout gestation, 
PSG serum levels rise exponentially to reach a final concentration of 200-400ug/ml, primarily 
as a consequence of the increasing mass of the placenta. The decay of radioimmuno assayable 
PSG in post partum serum appears to be faster during the first 24 hours than later, with a first 
half-life (0-24 hours after delivery) of 20 hours and a subsequent one (after 24 hours) of 72 
hours (Huttenmoser et al., 1987). 
Three major PSG mRNA can been detected in placental tissue and in primary cultures of 
trophoblasts (Chou and Plouzek, 1992). They are 2.3, 2.2 and 1.7 kb in size and each 
represents a group of transcripts of similar size. Streydio and Vass art ( 1990) used specific 
oligonucleotides to detect PSGla, le, le, 2, 3 and 11 by hybridisation in human placenta at 
different stages of gestation. They concluded that throughout the duration of pregnancy, PSG 
are expressed in a constant way, with no evidence for developmental regulation, at least for the 
PSG investigated. Some PSG are preferentially expressed however, PSGla, 2 and 3 were 
present at higher levels than PSG 1 c, 1 e and 11 . 
Further evidence for differential expression patterns of individual PSG genes in the placenta 
has arisen from a recent analysis of PSG gene promoters. Chamberlin et al. ( 1994) 
characterised the promoters of six PSG genes and have shown that they fall into two classes 
Colour scheme: 
Maternal tissue 
Syncytiotrophoblast 
Cytotrophoblast 
Ectoderm 
Grey 
Red 
Pink 
White with black nuclei 
Endoderm Orange 
Extra-embryonic mesoderm Purple 
Maternal blood corpuscles Red within dark circles 
FIG. 3. A schematic representation of a human implantation site at an estimated age 
bf 11-12 days (from Hamilton et al., 1972). 
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which differ in their requirement for activator elements. Modulation of PSG gene expression is, 
at least in part, achieved by the abundance or availability of certain transcription factors and 
their interactions with both positive and negative DNA elements in the PSG promoters. 
There is some experimental evidence for tissue specific expression of PSG. Work done by 
Leslie et al. (1990) indicates that the PSG6r transcript may be expressed only in hydatidiforrn 
mole. It may be possible to exploit this and develop mole-specific probes to enable early 
detection and diagnosis . 
While the placenta is the major site of PSG synthesis and expression, PSG proteins are neither 
female or pregnancy specific. PSG cDNA clones have been isolated from libraries of testis 
(Borjigin et al. , 1990), foetal liver (Khan and Harnmarstrom, 1989, Zimmerman et al., 1989), 
salivary gland and intestine (Zoubir et al. , 1990), HeLa cells (Chan et al. , 1988a and b ), 
myeloid cell lines (Barnett et al., 1990, Oikawa et al., 1989a), leukocytes, neutrophils and 
polymorphonuclear cells (Wu et al. , 1993). PSG protein synthesis however, has only been 
demonstrated in primary cultures of placental trophoblasts , fibroblasts , amnion cells and some 
human tumour cell lines (Chou and Plouzek, 1992). 
All PSG except PSG 11 w are secreted. PSG 11 w is predicted to have a hydrophobic C terminus 
of 81 amino acids (Chan et al. , 1991). Preliminary studies on the in vitro expression of this 
transcript in eukaryotic cells suggest that PSGl 1 w remains within the cells, and in fact, is not 
transported to the golgi bodies but remains bound to the endoplasmic reticulum until it is 
degraded (Chen et al. , 1993 ). 
Clinical applications. 
There are a number of clinical applications for the levels of PSG in pregnant serum but these 
are not used diagnostically in New Zealand. 
PSG levels have been used to diagnose pregnancy but are generally considered to be less 
sensitive than the current hCG tests. Low levels of PSG can predict threatened abortion (Hertz 
and Schultz-Larsen, 1986, Masson et al., 1983) or ectopic pregnancy (Sterzik et al. , 1989) and 
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other complications such as foetal growth retardation and intrauterine foetal death when taken 
in conjunction with ultrasound scans (Chou and Plouzek, 1992, Bischof, 1984, Tamsen et al. , 
1983). High PSG levels in the amniotic fluid correlate with Meckels syndrome (Heikinheimo et 
al. , 1982). Downs syndrome can be predicted with around 78% accuracy when PSG levels are 
considered in conjunction with hCG, a-fetoprotein and maternal age (Petrocik et al. , 1990). 
PSG levels and hCG concentrations are useful for detecting gonadotrophin induced pregnancy, 
as arises in artificial fertility programmes (Rosen, 1986). 
PSG levels are used as a prognosis index in breast cancer patients (Home et al. , 1976, Fagnart 
et al. , 1985, Wright et al. , 1987) and as an indicator to monitor treatment of choriocarcinomas, 
hydatidiform mole and gestational trophoblast disease (Tatarinov, 1978). The uses of PSG6r as 
a probe for the early detection ofhydatidiform mole and possibly choriocarcinomas is currently 
in progress (Leslie et al., 1990). 
The PSG in other animals. 
Proteins similar to the PSG found in humans have been detected in other mammals such as 
rodents , sheep and cows. They are however, structurally distinct from human PSG (Thompson 
etal. , 1991 , Chan et al. , 1988c, Turbide et al. , 1991). 
1.3 The CEA Subfamily. 
In 1965, Gold and Freedman identified carcinoembryonic antigen as a foetal and colonic 
cancer antigen present in colonic tumours and foetal gut (Gold and Freedman, 1965). Although 
CEA has since been detected at low concentrations in a range of normal tissues (Chu et al. , 
1972 ), in some benign tumours (Kuroki et al. , 1984) and in other tumours e.g. breast tumours, 
it is still one of the most widely used human tumour markers for assessing the treatment of 
colorectal, breast and lung cancers . 
Since the discovery of CEA, other closely related genes and proteins have been identified. As 
well as the PSG subfamily of proteins, two other CEA subgroup members are well 
characterised. These are non-specific cross-reacting antigen (NCA) and biliary glycoprotein-1 
FIG. 4. Structure and organisation of the CEA subfamily 
cDNA and the CEA gene. 
The domain structure of three CEA subfamily cDNA is based on 
deduced amino acid sequence (CEA from Oikawa et al. , 1987, 
NCA from Neumaier et al. , 1988 and BGP from Hinoda et al ., 
1988). The CEA gene (Schewe et al., 1990) contains exons that 
encode part of the leader peptide (L ), the rest of the leader peptide 
and a complete N-terminal domain (N), central repeat domains (Al , 
B 1, A2, B2, A3 , B3) and a transmembrane C-terminal domain (M) 
and 3 'UTR. The 3 'UTR sequences are shown as clear boxes on the 
map. The genes for NCA and BGP are not fully characterised but it 
is known that the different numbers of central repeat domains 
occurs as a result of gene organisation rather than alternative 
splicing. The domain ' A' is a BGP-specific A-like domain and the 
domain 'C' is a cytoplasmic domain. 
SOME cDNA OF THE CEA SUBFAMILY 
CEA S'UTR N Al Bl A2 B2 -A3 ] !!DM 3'UTR 
BGP 5'UTR L N Al Bl 'A' C 3'UTR 
NCA 
~LI N I Al I Bl ~I 3'UTR 
200bp 
GENOMIC ORGANISATION OF CEA 
L L\N Al Bl A2 B2 A3 B3 M-3'UTR 
-1- --- -H-- -1- --~1 r E3 
1KB 
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(BGP) which can be isolated from the colonic mucosa, serum, saliva, bile and faeces of normal 
individuals (Neumaier et al. , 1988, Barnett et al. , 1989, Hinoda et al. , 1988). Both these 
protein classes are immunologically crossreactive and share substantial sequence identity with 
CEA Unlike the PSG, the CEA, NCA and BGP proteins can be membrane associated. 
Other members of the CEA subgroup include a 128-k.Da colon tumour associated antigen 
(TEX) and two meconium antigens of molecular weights 160-k.Da and 100-k.Da (Neumaier et 
al. , 1988). Whether these are products of uncharacterised genes or isoforms of known genes 
remains to be determined. 
Recently other CEA gene-family member (CGMl-18) genes have been identified (Olsen et al ., 
1994) but as yet their transcriptional status is not known. 
Primary structure and genomic organisation of the CEA subfamily 
The primary structures of CEA, BGP and NCA proteins as predicted from nucleotide sequence 
data, are shown in FIG. 4. A short leader peptide of 30-34aa (L) is followed by an N-terminal 
domain of 108aa. The number of central domains (A-type, 93aa and B-type, 85aa) varies 
between subfamily members but in contrast to the PSG subfamily, this is as a result of gene 
organisation and not alternative splicing. As with the PSG, the N domain is Ig-V-like and the 
central domains are IgC2-like (Williams, 1987). The N domain and central A and B domains of 
PSG and CEA share around 60% homology (Streydio et al. , 1988). 
In contrast to the PSG, members of the CEA subfamily are typically membrane bound and 
have a hydrophobic membrane spanning domain (M) of 26aa at the C-terminus. BGP proteins 
have a cytoplasmic domain (C) of 71 aa in addition to the M domain. 
The genomic organisation of CEA is shown in FIG.4. The genomic organisation of NCA and 
BGP has not yet been fully established. 
The structure of CGMl 3-CGMl 8 has been characterised by the partial sequencing of these 
new genes (Teglund and Harnmarstrom, 1994 ). They share identical gene organisation. A 
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single A domain is separated from a single B domain by 0.4kb. These domains share more than 
95% identity at the nucleotide level. Approximately 6kb downstream from the end of the B 
domain is a region that shares 95% identity to PSG C termini and includes exons for the PSG 
C-terminal domains Ca, Cb and Cc. These CGM genes do not have exons encoding CEA/PSG 
-like N domains. It is not yet known whether these genes produce functional transcripts. 
Biological roles of CEA subfamily 
CEA, NCA and BGP proteins are highly glycosylated. CEA has 28 potential glycosylation sites 
and the carbohydrate moiety may comprise up to 60% of the total molecular weight (Thompson 
etal. , 1991). 
A biological activity has been established in vitro for CEA, NCA and BGP. CEA and NCA 
have been shown function in vitro as intercellular Ca2+ -independent adhesion molecules 
(Benchimol et al. , 1989, Oikawa et al. , 1989b) which indicates a possible role in intestinal 
tissue organisation during development. 
CEA and NCA both have a specific affinity for binding certain strains of E.coli , by way of a 
bacterial lectin / CEA carbohydrate interaction (Thompson et al. , 1991). Thus CEA may have a 
role in establishing intestinal flora while NCA on the surface of granulocytes, may facilitate 
phagocytosis . 
Another possible role for CEA on the surface of migrating embryonic cells or metastasising 
tumour cells, may be in mediating interactions with basement membranes. CEA has been 
shown to facilitate binding of a colonic adenocarcinoma cell line to collagen type 1 in vitro 
(Thompson and Zimmerman, 1988). Also there is some evidence that CEA may direct 
metastases from colorectal cancers to the liver by binding a specific receptor on Kupffer cells 
(cells of the liver, responsible for removing CEA from the circulation) then interacting with 
CEA on tumour cell surfaces in a homotypic fashion, immobilising them and enabling the 
establishment of secondary tumours (Thomas and Toth, 1990). 
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BGP, unlike CEA and NCA, is reportedly Ca2+ - and temperature-dependent in its binding 
properties. Sequence homology to a rat ecto-A TPase may indicate a possible enzymatic role for 
these members of the CEA gene family (Turbide et al., 1991 , Rojas et al. , 1990). 
1.4 The Biological Role(s) of PSG 
Unlike the CEA subgroup, PSG are predominantly secreted proteins. It is likely therefore that 
they act through cellular receptors to mediate cellular interactions. 
Four potential roles for the PSG have been suggested, they are : 
• immunosuppression and the prevention of immune rejection of the foetus (Watanabe and 
Chou, 1988a, Borjigin et al. , 1990) 
• an involvement in the invasion of the uterus by the trophoblast (Streydio et al. , 1988) 
• a role in cellular interactions with the extracellular matrix (Rooney et al. , 1988) 
• and growth factor activity (Wu et al. , 1993, Zheng et al. , 1990) 
Experimental results, using bulk PSG (i.e. unfractionated PSG isolated from maternal serum) 
show that the PSG may interact directly with T cells, interfering with their normal interactions 
and thereby bringing about some form of immunosupression. It has been reported that PSG 
inhibit E-rosette formation, in a concentration dependent manner, which implies the (T-cell) 
CD2 : LF A-3 (erythrocyte) interaction is disrupted (Kan and Tatarinov, 1990). The PSG have 
also been reported to affect the proliferative activity of phytohaemagglutinin-stimulated 
lymphocytes (Bischof, 1984) and inhibit stimulated lymphocytes in a mixed lymphocyte assay 
(Zheng et al., 1990). 
Since bulk PSG was used for the above experiments, specific interactions could not be 
identified. The purity of bulk PSG is questionable, especially in the light of contamination by 
highly potent bioactives such as cytokines and components of the extracellular matrix. 
Furthermore, the above assays each involve different T-cell receptors so it is not clear whether 
different PSG bind different receptors or whether they act indirectly, by binding initially 
uninvolved receptors. One hypothesis, currently under investigation by our group, is that 
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PSG 11 binds specific receptors that are involved in the switch to and/or the maintenance of 
antibody-mediated immunity and suppression of cell-mediated immunity, typical of pregnancy. 
The presence of the RGD motif in some PSG suggests a role either in the invasion of the 
maternal tissue by the trophoblast or in the mediation or co-ordination of cell-cell interactions 
during embryogenesis (Rooney et al., 1988, Streydio et al. , 1988). As discussed previously the 
RGD tripeptide is present in extracellular matrix proteins, has been shown to be a signal that is 
recognised by specific cellular receptors and has a role in controlling cell adhesion and cell 
migration on substrates (Streydio et al. , 1988, Ruoslahti and Piersbacher, 1987). Further, there 
is evidence of some amino acid sequence homology, albeit weak, between the PSG domains 
and N-CAM, fibronectin and vitronectin, three well characterised cell adhesion molecules 
(Rooney et al. , 1988). A role such as the two described above may well be consistent with the 
expression of PSG in tumours such as breast tumours, hydatidiforrn mole or choriocarcinomas. 
Some viruses contain the RGD motif in their protein coats and are able to infect human cells 
through integrin receptors on the cell surface (Bergelson and Finberg, 1993). Perhaps one of 
the roles of the PSG is to block these receptors, in a non-specific manner during pregnancy. 
Another role proposed for the PSG is as a growth enhancer for the cells of the haematopoeitic 
system. Using reverse transcriptase PCR, Wu et al. (1993) were able to isolate most known 
PSG transcripts from bone marrow and peripheral blood. The levels of expression of PSG 
transcripts from T lymphocytes were comparable to placental levels . The placenta is known to 
be a rich source ofhaematopoietic growth factors and PSG transcripts have also been isolated 
from foetal liver, a primary site of haematopoeisis in the developing foetus . This potential 
biological activity is currently under investigation. 
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1.5 Evolution of the PSG and CEA Multigene Family 
Like most multigene families e.g. proteins of the blood clotting system, globin genes ( Li and 
Graur, 1991) collagens (Buttice et al., 1990), the PSG /CEA multi-gene family shows an exact 
correspondence between protein structural domains and exons (see FIGs 2 and 4). The 
different domains within each PSG locus also show significant similarity to each other. This 
indicates both that duplication of domains has occurred and that a single ancestral domain was 
a precursor in the evolution of this gene family (Streydio et al., 1990). 
A possible scenario for the evolution of the PSG family is as follows : 
• The precursor ( or primordial exon) was A or B domain-like and contained two conserved 
cysteine (Cys) residues with possibly an lg-like fold. This molecule may have undergone a 
series of internal duplications to give a number of similar domains 
• One of these domains could have then lost its Cys residues through reduced selective 
pressure, to become the N terminus 
• Then followed a series of further duplications of the A-B unit, and/or rearrangement by 
unequal crossing over to give a variable number of central domains ,and/or duplication of 
complete gene units to give multiple genes (Streydio et al. , 1990) 
Relevant to the question of origins of PSG is the process of concerted evolution. This is a term 
used to describe the observed homogeneity among members of a gene family, when processes 
are thought to act to prevent individual members of a family from evolving independently of 
other members. Thus, the family evolves as a unit, in a concerted fashion. Both the mechanism 
of unequal crossing over and that of gene conversion are thought to contribute to the process of 
homogenisation in concerted evolution (Li and Graur, 1991). 
It would appear that the CEA/PSG genes have evolved by concerted evolution at least in part, 
by a mechanism of unequal crossing over . This is suggested by the observation that CEA 
family members (e.g. CEA, NCA, BGP) each have a different number of central domains (see 
FIG. 4). These may well be functional products of unequal cross over events. In contrast to the 
PSG 11-1/II 
PSG3 
PSG5-I/I1 
I 
PSG13 
PSG12 
PSG8 -I/II 
PSG7 -I/II 
PSGI-1/Il 
PSG2 
PSG4/9 
PSG6/ 10 
FIG. 5. Strict consensus of tied optimal trees found under parsimony using N 
domain sequences (from Khan et al., 1992). 
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CEA subfamily, in the PSG subfamily all genes have the same four central domains (see FIG. 
2) and different subfamily members appear to have arisen by the duplication of complete loci . 
This is further suggested from the intron and pseudogene sequences which show extensive 
similarity also (Rudert et al. , 1989). 
A multi-gene family encoding proteins similar to the PSG/CEA human proteins has been found 
in rodents . Early analysis ( Rudert et al., 1989, Thompson et al. , 1989) indicated that the two 
families are non identical and that they have been evolving by parallel gene duplication and 
subsequent divergence since the mammalian radiation. 
The reconstructed evolutionary tree shown in FIG. 5 is that found by Khan et al. (1992) in a 
comparative analysis of N-terminal PSG sequences. It was suggested by these authors to 
represent the evolutionary relationships between PSG genes. 
However, the PSG can be divided into three subgroups according to their types of C-termini 
(see Table 2 and FIG 2). In the tree presented by Khan et al. (1992) in FIG. 5, the different 
subgroups do not cluster together as would be expected if they shared a more recent common 
ancestor with other members of the same subgroup. In their reconstructed tree some subgroup 
1 members join more closely with members of subgroups 2 or 3 ( e.g.PSGl and PSG2, PSG4 
and PSG6). 
1.6 Aims and Objectives. 
No complete subgroup 3 PSG gene has been isolated or characterised. 
A partial cDNA for PSG3 was isolated by myself and Dr. Mansfield in 1989, from a placental 
cDNA library (McLenachan and Mansfield, 1989). This cDNA was used by Ms.S.Sims to 
probe a human genomic cosmid library. Several cosmids were isolated and one of these, 
hC3 .11 , was partly characterised by myself and others of our group (Beggs, 1990, Joe, 1994, 
Joe et al., 1994,) and was found to contain the L, N, A 1, B 1, A2 and B2 exons of the PSG 11 
gene. A map of the cosmid hC3 .11 showing regions that have been sequenced is presented in 
FIG.6. 
hC3.11 
--> -> 
BEE E B E E E E B 
11 I ~ ~ 2kb I~ 
t * LL/N AlBl A2B2 
FIG. 6. A map of the cosmid hC3.ll which contains part of the PSGll gene. 
Sites for the restriction enzymes BamHI and EcoRI are labelled. The exons for the Leader sequence (L), 
the N-terrninal domain (N), the central domains (A I, A2, B2) and the B 1 pseudoexon are shown as 
coloured boxes. Broken arrows above the map indicate regions of sequence obtained by our group (Beggs, 
1990, Joe, 1994 , Joe et al, 1994, McLenachan et al, 1994). The upstream region of PSG 11 that is largely 
uncharacterised is arrowed . The 0.5kb BamHI - EcoRI fragment used as a probe (see text) is marked*. 
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The primary aim of this project was to complete the characterisation of the PSG 11 gene. The 
isolation, mapping and sequence determination from this locus has now been published 
(McLenachan et al., 1994). A secondary aim was to examine the evolution of the PSG genes 
using new sequences from the 3' region of a subgroup 3 gene. The hypothesis of relationship as 
proposed by Khan et al., (1992) (FIG. 5) was tested and this work is currently submitted for 
publication (McLenachan et al., 1995). An important focus of the evolutionary analysis 
presented here, has been the attempt to separate historical signals from other (perhaps 
functional) patterns in the data. 
Extensive characterisation of this extremely complex gene family will enable rational 
investigations into a biological role for PSG to be carried out and may provide further clues as 
to evolutionary history of the family. 
